Search research articles
Contact Us
Filters
Showing results (51-60 of 65) with videos related to
Page
of 7
Sort By:
Clinical Radiology
|
August 15, 2006
Intraductal papillary mucinous tumour of the pancreas: differentiation of malignancy and benignancy by CT
S S-h Chiu, J H Lim, W J Lee, et al.
European Journal of Cardiovascular Nursing
|
March 21, 2025
Resistance-based exercise intervention for patients with coronary artery disease and sarcopenia: A pilot randomized controlled trial
Polly W C Li, Doris S F Yu, N Y Chan, et al.
Journal of Medicinal Chemistry
|
July 3, 1998
1-[2(R)-(2-amino-2-methylpropionylamino)-3-(1H-indol-3-yl)propionyl]- 3-benzylpiperidine-3(S)-carboxylic acid ethyl ester (L-163,540): a potent, orally bioavailable, and short-duration growth hormone secretagogue
L Yang, G Morriello, A A Patchett, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
September 1, 1988
Metabolism of kadsurenone and 9,10-dihydrokadsurenone in rhesus monkeys and rat liver microsomes
K L Thompson, M N Chang, J C Chabala, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
October 8, 1998
Disposition of L-732,531, a potent immunosuppressant, in rats and baboons
B V Karanam, R R Miller, A Colletti, et al.
Journal of Medicinal Chemistry
|
March 4, 1994
1-((7,7-Dimethyl-2(S)-(2(S)-amino-4-(methylsulfonyl)butyramido)bicyclo [2.2.1]-heptan-1(S)-yl)methyl)sulfonyl)-4-(2-methylphenyl)piperaz ine (L-368,899): an orally bioavailable, non-peptide oxytocin antagonist with potential utility for managing preterm labor
P D Williams, P S Anderson, R G Ball, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
December 1, 1996
Orally active inhibitors of human leukocyte elastase. I. Disposition of L-683,845 in rats and rhesus monkeys
S H Vincent, S K Painter, P A Krieter, et al.
Age and Ageing
|
May 12, 2026
Outcome domains of patient-reported outcome measures used in randomised controlled trials for older adults with non-specific low back pain: a systematic review
Tony S H Chiu, Jae Q J Liu, Edmond C M Wong, et al.
International Journal of Systematic Bacteriology
|
November 11, 1999
Mycobacterium wolinskyi sp. nov. and Mycobacterium goodii sp. nov., two new rapidly growing species related to Mycobacterium smegmatis and associated with human wound infections: a cooperative study from the International Working Group on Mycobacterial Taxonomy
B A Brown, B Springer, V A Steingrube, et al.
International Journal of Systematic and Evolutionary Microbiology
|
October 12, 2001
Mycobacterium immunogenum sp. nov., a novel species related to Mycobacterium abscessus and associated with clinical disease, pseudo-outbreaks and contaminated metalworking fluids: an international cooperative study on mycobacterial taxonomy
R W Wilson, V A Steingrube, E C Böttger, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 65) with videos related to
Sort By:
Page
of 7
Clinical Radiology
|
August 15, 2006
Intraductal papillary mucinous tumour of the pancreas: differentiation of malignancy and benignancy by CT
S S-h Chiu, J H Lim, W J Lee, et al.
European Journal of Cardiovascular Nursing
|
March 21, 2025
Resistance-based exercise intervention for patients with coronary artery disease and sarcopenia: A pilot randomized controlled trial
Polly W C Li, Doris S F Yu, N Y Chan, et al.
Journal of Medicinal Chemistry
|
July 3, 1998
1-[2(R)-(2-amino-2-methylpropionylamino)-3-(1H-indol-3-yl)propionyl]- 3-benzylpiperidine-3(S)-carboxylic acid ethyl ester (L-163,540): a potent, orally bioavailable, and short-duration growth hormone secretagogue
L Yang, G Morriello, A A Patchett, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
September 1, 1988
Metabolism of kadsurenone and 9,10-dihydrokadsurenone in rhesus monkeys and rat liver microsomes
K L Thompson, M N Chang, J C Chabala, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
October 8, 1998
Disposition of L-732,531, a potent immunosuppressant, in rats and baboons
B V Karanam, R R Miller, A Colletti, et al.
Journal of Medicinal Chemistry
|
March 4, 1994
1-((7,7-Dimethyl-2(S)-(2(S)-amino-4-(methylsulfonyl)butyramido)bicyclo [2.2.1]-heptan-1(S)-yl)methyl)sulfonyl)-4-(2-methylphenyl)piperaz ine (L-368,899): an orally bioavailable, non-peptide oxytocin antagonist with potential utility for managing preterm labor
P D Williams, P S Anderson, R G Ball, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
December 1, 1996
Orally active inhibitors of human leukocyte elastase. I. Disposition of L-683,845 in rats and rhesus monkeys
S H Vincent, S K Painter, P A Krieter, et al.
Age and Ageing
|
May 12, 2026
Outcome domains of patient-reported outcome measures used in randomised controlled trials for older adults with non-specific low back pain: a systematic review
Tony S H Chiu, Jae Q J Liu, Edmond C M Wong, et al.
International Journal of Systematic Bacteriology
|
November 11, 1999
Mycobacterium wolinskyi sp. nov. and Mycobacterium goodii sp. nov., two new rapidly growing species related to Mycobacterium smegmatis and associated with human wound infections: a cooperative study from the International Working Group on Mycobacterial Taxonomy
B A Brown, B Springer, V A Steingrube, et al.
International Journal of Systematic and Evolutionary Microbiology
|
October 12, 2001
Mycobacterium immunogenum sp. nov., a novel species related to Mycobacterium abscessus and associated with clinical disease, pseudo-outbreaks and contaminated metalworking fluids: an international cooperative study on mycobacterial taxonomy
R W Wilson, V A Steingrube, E C Böttger, et al.
Page
of 7